Found 0 matching trials
Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma PHASE2 To evaluate safety and efficacy of combined hepatic arterial infusion (HAIC...
Show More Location
Cancer Center, Sun Yat-sen University
Learn More & Join Trial
HAIC Combined With Donafenib and Sintilimab for Unresectable ICC PHASE2 To evaluate the safety and tolerability of HAIC combined with donafenib and...
Show More Location
Zhongda Hospital, Southeast University
Learn More & Join Trial
HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. PHASE3 The purpose of this study is to evaluate the efficacy and safety of hepatic...
Show More Location
The First People's Hospital of Foshan
Learn More & Join Trial
DEB-TACE+HAIC vs. HAIC for Large HCC PHASE3 This study is conducted to evaluate the efficacy and safety of transarteria...
Show More Location
the Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study PHASE3 Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin\&5-fluoroura...
Show More Location
The First People's Hospital of Foshan
Learn More & Join Trial
Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma PHASE2 Hepatic artery infusion chemotherapy (HAIC) is a locoregional therapy commo...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma PHASE2 The purpose of this study is to evaluate the efficacy and safety of Adabrel...
Show More Location
Gansu Province Cancer Hospital
Learn More & Join Trial
HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B PHASE2 The purpose of this study is to evaluate the efficacy and safety of hepatic...
Show More Location
Cancer Center Sun Yat-sen University
Learn More & Join Trial
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents NA Immune checkpoint inhibitors (ICIs) plus antiangiogenic agents can achieve ...
Show More Location
Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) PHASE2 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Learn More & Join Trial